Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients

Adriana Perilla-Glen
Dec 3, 2016
1 min read

Updated: Sep 28, 2018

Irene Ghobrial, MD of Dana-Farber Cancer Institute, Boston, MA, discusses the benefits of early therapeutic interventions for patients with high-risk smouldering multiple myeloma (MM). +watch video

Recent Posts

See All

Katie Couric Helps Spread the Word About Why Blood Cancer is Often Diagnosed Too Late

Tom Brokaw - Shining a Light on Early Diagnosis Options

Ask A Multiple Myeloma Expert - Public Webinar Series Pt. 1

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.